entertainment -WSS

entertainment

author：entertainment 2025-10-02 22:24:39 - browse：62

gantenerumab Alzheimer's disease Roche — Sebastien Bozon/AFP via Getty Images

Roche said Monday it was buying Telavant Holdings for $7.1 billion upfront, picking up a promising experimental therapy for inflammatory bowel diseases.

Telavant is owned by Roivant Sciences, with Pfizer holding a minority stake. The deal will allow Roche to develop the therapy, called RVT-3101, and, pending approval, sell it in the United States and Japan. Pfizer holds the commercial rights in other parts of the world.

The “Roi” in Roivant stands for “return on investment” and with this deal, the biotech, founded by Republican presidential candidate Vivek Ramaswamy but now run by CEO Matt Gline, certainly delivered. Last December, it essentially acquired RVT-3101 from Pfizer for $45 million and a commitment to invest in the drug’s development. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Chronically ill young patients struggle to find fertility info

leisure time

WSS

Hospitals look to new technology to keep health care workers safe

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

JPM: CVS says Medicare Advantage patients are impacting profits

Poor hospice wound care hurts patients and families

Goldman Sachs launches $650M fund for life science investments

GSK Flovent asthma inhalers replaced by authorized generics

knowledge

entertainment

hotspot

Activists slam private health insurers over coverage restrictions

Astellas still sees hope in its gene therapy after four deaths

Malaria cases in Florida and Texas: Here’s what you need to know

Chronically ill young patients struggle to find fertility info

Medical records are filled with copy

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Medical records are filled with copy

Gain of function research would be limited under House proposal

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

U.K. sequencing study surfaces new findings about tumor DNA

focus

3 trends to watch in health tech's hiring outlook for 2024

Congress must reauthorize a committee to support older Americans

The FDA must approve intranasal treatments for anaphylaxis

In key trial, Verve's treatment lowers cholesterol levels in patients

Weight loss drug costs may need more research, senator suggests

New weight loss drugs work. But how can they best be used?

leisure time

explore

focus

hotspot